scholarly journals Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

Hepatology ◽  
2007 ◽  
Vol 46 (5) ◽  
pp. 1453-1463 ◽  
Author(s):  
James H. Lewis ◽  
Mary Ellen Mortensen ◽  
Steven Zweig ◽  
Mary Jean Fusco ◽  
Jeffrey R. Medoff ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Multicenter Trial ◽  
Chronic Liver ◽  
High Dose ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study

2002 ◽  
Vol 87 (6) ◽  
pp. 2751-2759 ◽  
Author(s):  
Jennifer D. Wallace ◽  
Winsome J. Abbott-Johnson ◽  
Darrell H. G. Crawford ◽  
Ross Barnard ◽  
Julia M. Potter ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Gh Treatment ◽  
Double Blind ◽  
Double Blind Placebo

Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Yu-Jun Wong ◽  
Tian-Yu Qiu ◽  
Gin-Kee Ng ◽  
Qishi Zheng ◽  
Eng Kiong Teo
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document